ARCHIVES

FDA Rejects Genentech Bid For Accelerated Approval For T-DM1. NCI Breaks Ground For Satellite Campus At Shady Grove

This article is from The Cancer Letter archive.

Vol. 36 No. 31 | September 3, 2010

Download PDF Visit The Full Archive

Related Articles

Contract Authority Expiration Confuses NCI Money Bill Estimates, Which Range From $605 To $650 Million

June 21, 1974

Antibody Targeting PD-L1 Shows Fast Tumor Shrinkage

May 31, 2013

Studies of Oncotype DX Test Presented at ASCO Symposium

January 31, 2014

DCBD Board Rejects Breast Cancer Multiple Markers Concept Proposal

November 4, 1983

House Committee Begins Investigation Of NCI’s National Lung Screening Trial.

October 26, 2007

Clearinghouse Delves Into Carcinogenesis Issues – Test Validity, Interpretation, In Vitro Methods

August 12, 1977